DAHANCA
|
WikiDoc Resources for DAHANCA |
|
Articles |
|---|
|
Most recent articles on DAHANCA |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on DAHANCA at Clinical Trials.gov Clinical Trials on DAHANCA at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on DAHANCA
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating DAHANCA Risk calculators and risk factors for DAHANCA
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for DAHANCA |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
DAHANCA refers to the "Danish Head and Neck Cancer Study". It actually refers to a series of studies, the most recent of which is "DAHANCA 10". Other notable studies include DAHANCA 5[1] and DAHANCA 6/7.[2]
It operates under the authority of the Danish Society for Head and Neck Oncology.
See also
References
- ↑ Eriksen JG, Overgaard J (2007). "Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: An evaluation of the DAHANCA 5 study>". doi:10.1016/j.radonc.2007.05.009. PMID 17543403.
- ↑ Overgaard J, Hansen HS, Specht L; et al. (2003). "Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial". Lancet. 362 (9388): 933–40. PMID 14511925.